COVID-19 impact on cancer patients: MUHC researchers take part in a multinational study
Published in The Lancet, the study reveals cancer-specific factors associated with increased mortality
Why do some non-smokers get COPD while many heavy smokers don’t?
A new study highlights a strong risk factor for COPD related to lung development
Hydroxychloroquine not effective in preventing the development of COVID-19 when used as post-exposure prophylaxis
A new study suggests that hydroxychloroquine is not effective in preventing the development of COVID-19 in individuals exposed to SARS-CoV-2
Interim Leadership of the Research Institute of the MUHC
The Board of Directors of the RI-MUHC is pleased to announce the appointment of Dr. Miguel N. Burnier, Jr. to the position of Interim Executive Director and Chief Scientific Officer of the RI-MUHC
Made-in-Canada COVID-19 test developed at McGill receives government support
Government support for McGill and RI-MUHC team in COVID-19 testing
COVID-19 Q&A: Tina Montreuil on helping children cope with anxiety
“It is not only what you say that matters, but what you do”
The RI-MUHC receives and tests the first UV-Disinfection robot in Canada
Novel robotics technology could potentially reduce healthcare-associated infections
RI-MUHC investigator joins Global Consortium of Chemosensory Researchers (GCCR) in rapid response to COVID-19
GCCR group develops worldwide survey on smell loss
International consortium investigates overactive immune cells as cause of COVID-19 deaths
New publication links neutrophil infiltration in the lungs of patients to COVID-19 symptoms
FRQ to create a province-wide COVID-19 Biobank
RI-MUHC researchers take leading roles in the initiative